Brecanavir

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Brecanavir
Brecanavir structure.svg
Clinical data
ATC code none
Identifiers
CAS Number 313682-08-5 N
PubChem (CID) 5743186
ChemSpider 4675192 YesY
UNII E367I8C7FI YesY
ChEMBL CHEMBL206031 YesY
Chemical and physical data
Formula C33H41N3O10S2
Molar mass 703.82
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Brecanavir (INN; codenamed GW640385) is a protease inhibitor which has been studied for the treatment of HIV.[1]

On December 2006, its developer, GlaxoSmithKline discontinued further development because of insurmountable issues regarding formulation.[2]

See also[edit]

References[edit]